-
增强型快速综合征分子诊断溶液可检测多种传染病
- 来源: https://www.labmedica.com/microbiology/articles/294801045/enhanced-rapid-syndromic-molecular-diagnostic-solution-detects-broad-range-of-infectious-diseases.html
- 101
- 2024-05-04
-
美国食品药品监督管理局批准新型赫赛汀生物类似物用于治疗多种HER2过表达癌症
- 来源: https://www.pharmexec.com/authors/don-tracy-associate-editor
- 129
- 2024-05-04
-
赛诺菲授权的药物成为美国食品药品监督管理局批准的首个治疗超罕见原发性免疫缺陷的药物
- 来源: https://medcitynews.com/author/fvinluan/
- 112
- 2024-05-04
-
Cardinal收到美国FDA关于未经批准的注射器的警告信
- 来源: https://www.medtechdive.com/news/cardinal-warning-letter-unapproved-syringes/714934/
- 162
- 2024-05-04
-
GlobalData：阿斯利康的 Lynparza 将在 2027 年以 40 亿美元的销售额主导 PARP 抑制剂市场
- 来源: https://www.expresspharma.in/astrazenecas-lynparza-to-dominate-parp-inhibitors-market-with-4-bn-in-sales-by-2027-globaldata/
- 131
- 2024-05-04
-
BD 印度静脉峰会重点关注改善患者护理的最佳实践
- 来源: https://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/entry_191059.pdf
- 146
- 2024-05-04
-
Senseonics获得美国FDA批准将CGM植入物与胰岛素泵配对
- 来源: https://www.medtechdive.com/news/senseonics-fda-clearance-integrated-cgm/714804/
- 198
- 2024-05-03
-
阿西莫夫慢病毒产量提高10倍，推出新的稳定细胞系开发服务
- 来源: https://www.news-medical.net/news/20240430/Asimov-achieves-10x-improvement-in-lentiviral-production-launches-new-stable-cell-line-development-service.aspx
- 148
- 2024-05-03
-
深势科技 DevDay 2024 展示大型科学模型并宣布开放科学计划
- 来源: https://en.prnasia.com/releases/global/dp-technology-devday-2024-showcases-large-science-models-and-announces-open-science-initiative-445188.shtml
- 122
- 2024-05-03
-
FDA 批准 X4 制药公司的 WHIM 综合征药物
- 来源: https://www.pharmaceutical-technology.com/news/fda-x4-syndrome-drug/?cf-view
- 120
- 2024-05-03
